Clinical Trial Update: Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients [NA]

View source ↗

Summary

A completed study assessing the use and tolerability of imatinib mesylate (Gleevec) in patients with leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | NA | Status: COMPLETED